News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
ASELAGE STEVE
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/16/2023 |
4
| ASELAGE STEVE (Director) has filed a Form 4 on Acer Therapeutics Inc.|
Txns:
| Granted 20,000 options to buy
@ $1.67, valued at
$33.4k
|
|
| 12/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/19/2022 |
4
| ASELAGE STEVE (Director) has filed a Form 4 on Acer Therapeutics Inc.|
Txns:
| Granted 18,500 options to buy
@ $2.21, valued at
$40.9k
|
|
| 12/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2021 |
4
| ASELAGE STEVE (Director) has filed a Form 4 on Travere Therapeutics, Inc.|
Txns:
| Sold 31,800 shares
@ $29.39, valued at
$934.6k
|
|
| 11/09/2021 |
4
| ASELAGE STEVE (Director) has filed a Form 4 on Travere Therapeutics, Inc.|
Txns:
| Sold 10,000 shares
@ $26.23, valued at
$262.3k
Exercised 10,000 options to buy
@ $16.23, valued at
$162.3k
|
|
| 11/03/2021 |
4
| ASELAGE STEVE (Director) has filed a Form 4 on Travere Therapeutics, Inc.|
Txns:
| Gifted 25,000 shares
@ $0
Gifted 25,000 shares
@ $0
Gifted 3,000 shares
@ $0
Gifted 3,000 shares
@ $0
Sold 5,000 shares
@ $29.48, valued at
$147.4k
Sold 3,500 shares
@ $30, valued at
$105k
|
|
| 10/08/2021 |
4
| ASELAGE STEVE (Director) has filed a Form 4 on Travere Therapeutics, Inc.|
Txns:
| Sold 28,000 shares
@ $26.23, valued at
$734.4k
Sold 32,000 shares
@ $26.26, valued at
$840.3k
Exercised 60,000 options to buy
@ $16.23, valued at
$973.8k
|
|
| 09/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2021 |
4
| ASELAGE STEVE (Director) has filed a Form 4 on Acer Therapeutics Inc.|
Txns:
| Granted 15,000 options to buy
@ $3.85, valued at
$57.8k
|
|
| 12/16/2020 |
4
| ASELAGE STEVE (Director) has filed a Form 4 on Travere Therapeutics, Inc.|
Txns:
| Sold 5,549 shares
@ $26.02, valued at
$144.4k
|
|
| 12/04/2020 |
4
| ASELAGE STEVE (Director) has filed a Form 4 on Travere Therapeutics, Inc.|
Txns:
| Gifted 3,000 shares
@ $0
Sold 7,891 shares
@ $23.4253, valued at
$184.8k
|
|
| 12/02/2020 |
4
| ASELAGE STEVE (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 1,956 shares
@ $5.11, valued at
$10k
|
|
| 11/06/2020 |
4
| ASELAGE STEVE (Director) has filed a Form 4 on Retrophin, Inc.|
Txns:
| Sold 2,500 shares
@ $21.26, valued at
$53.2k
Sold 20,625 shares
@ $23, valued at
$474.4k
|
|
| 09/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/28/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2020 |
4
| ASELAGE STEVE (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 1,112 shares
@ $4.495, valued at
$5k
|
|
| 05/19/2020 |
4
| ASELAGE STEVE (Director) has filed a Form 4 on Retrophin, Inc.|
Txns:
| Granted 3,000 shares
@ $0
Granted 9,000 options to buy
@ $15.43, valued at
$138.9k
|
|
| 05/14/2020 |
4
| ASELAGE STEVE (Director) has filed a Form 4 on Retrophin, Inc.|
Txns:
| Sold 1,000 shares
@ $17.16, valued at
$17.2k
Sold 4,063 shares
@ $16.41, valued at
$66.7k
Sold 3,062 shares
@ $15.09, valued at
$46.2k
|
|
|
|
|